Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 74.6 NOK Market Closed
Market Cap: 2B NOK

Gross Margin
Photocure ASA

93.4%
Current
94%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
93.4%
=
Gross Profit
488.3m
/
Revenue
522.9m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
NO
Photocure ASA
OSE:PHO
2B NOK
93%
US
Eli Lilly and Co
NYSE:LLY
1T USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
498.5B USD
68%
CH
Roche Holding AG
SIX:ROG
268.8B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
219.6B GBP
82%
US
Merck & Co Inc
NYSE:MRK
277.5B USD
79%
CH
Novartis AG
SIX:NOVN
219.4B CHF
76%
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
82%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
68%
US
Pfizer Inc
NYSE:PFE
144.8B USD
75%
No Stocks Found

Photocure ASA
Glance View

Market Cap
2B NOK
Industry
Pharmaceuticals

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

PHO Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
93.4%
=
Gross Profit
488.3m
/
Revenue
522.9m
What is the Gross Margin of Photocure ASA?

Based on Photocure ASA's most recent financial statements, the company has Gross Margin of 93.4%.

Back to Top